Cite
HARVARD Citation
Kwakwa, H. et al. (n.d.). 1263. Dolutegravir/Rilpivirine Switch Study in Persons with HIV and Chronic Kidney Disease: 24-week Assessment of Viral Suppression, Adherence, Treatment Satisfaction and Quality of Life. Open forum infectious diseases. p. . [Online].